You have read all your free articles, to continue reading subscribe to read the rest of this content.
How to better utilize the potential of digital tools In a new report Clearer rules and coordination of claims with recommendations to the benefit of patients, healthcare and business Uppsala BIO and others present eight proposals on how to better utilize the potential of digital products and serAlready a subscriber Login…
The new Centre for Intervention Science in Maternal and Child Health (CISMAC) in Bergen is seeking to find ways to effectively increase survival and enhance maternal and child health. Each year, some seven million children in low- and middle-income countries (LMICs) die before the age of five, anAlready a subscriber…
A multi-billion kroner agreement on a new pain-relief medication has been signed between the Norwegian innovation company, Inven2, and the pharmaceuticals giant, Merck. Public funding has played an important role in the Norwegian researchers’ success. The agreement confirms the vast potential oAlready a subscriber Login You have read all your…
An influenza drug created by Japan’s Fujifilm Holding Corp. could be approved to treat Ebola by the end of this year. The drug, Avigan, already has been used in Norway, France, Germany and Spain to treat Ebola patients. It was approved in Japan earlier this year to counter new forms…
